SmallCap
CompaniesStatistics

주식회사 사이키바이오텍

Venture Certified
Data Quality: 8/10

Basic Information


Unlisted

Company Name주식회사 사이키바이오텍
Business Reg. No.1448701921
CEO김은영
Address대전 유성구
Industry의학 및 약학 연구개발업
Industry Code70113
Main Products압타머 발굴 원천기술/치료제
EstablishedContact
Phone042-936-****
WebsiteContact
Regular EmployeesContact
Corp. Reg. No.160111-*******

Investment Metrics


Market Cap
-
Op. Margin
-70.13%
ROE
-7.13%
Debt Ratio
6.09%

Certification Status


Venture Certified

Cert. History
혁신성장유형2021-11-24 ~ 2024-11-23202111250301262021-11-24
혁신성장유형2024-11-24 ~ 2027-11-23202502040300862021-11-24

Financial Statements


3-Year Financial Data

Revenue CAGR -35.5%

Item202420232022
Revenue

2.0B

4.1B

4.9B

Operating Profit

-1.4B

-0.8B

-1.7B

Net Profit

-1.2B

-0.5B

-1.5B

Total Assets

17.3B

2.4B

2.8B

Total Liabilities

1.0B

0.4B

0.3B

Total Equity

16.4B

2.0B

2.5B

Risk Indicators


3 Risk Indicators

Comparison Metrics


vs. 3-Year Avg.
Based on 2024
Revenue
2B

55.1%

vs. 3-Year Avg.: 4B
Operating Profit
-1B

13.5%

vs. 3-Year Avg.: -1B
Op. Margin
-70.1%

159.1%

vs. 3-Year Avg.: -27.1%
Debt Ratio
6.1%

63.5%

vs. 3-Year Avg.: 16.7%
ROE
-7.1%

82.7%

vs. 3-Year Avg.: -41.3%

Officers / Major Shareholders


Only CEO info available (unlisted company)
NamePositionRole
김은영대표이사대표

Employment Status


Regular EmployeesContact
CEO김은영

Patent Status

Updated: 2026-02-25

No Data Contact

No patents found or data not yet available.

Procurement Record

Updated: 2026-02-25

No Data Contact

No procurement record or data not yet available

Support Programs


No Data Contact

No matching support programs for this industry

Tax / Business Status

Updated: 2026-02-25

Business Status: active
Tax Type부가가치세 일반과세자

SME Status


Venture
Status

Cert. flags confirmed (details update after further collection)

Other Public Data


1 Additional Data Sources

{
  "address": "대전 유성구",
  "ceo_name": "김은영",
  "certificate": [
    {
      "cert_number": "20211125030126",
      "changes": "",
      "disclosure_date": "2021-11-25",
      "first_cert_date": "2021-11-24",
      "no": "1",
      "type": "혁신성장유형",
      "valid_period": "2021-11-24 ~ 2024-11-23"
    },
    {
      "cert_number": "20250204030086",
      "changes": "",
      "disclosure_date": "2025-02-04",
      "first_cert_date": "2021-11-24",
      "no": "2",
      "type": "혁신성장유형",
      "valid_period": "2024-11-24 ~ 2027-11-23"
    }
  ],
  "company_name": "주식회사 사이키바이오텍",
  "corp_no": "160111-*******",
  "financials": {
    "2022": {
      "capital_stock": 222221000,
      "cost_of_sales": 387056000,
      "current_assets": 197145000,
      "current_liabilities": 33414000,
      "gross_profit": 98867000,
      "net_income": -146708000,
      "net_income_bs": -146708000,
      "non_current_assets": 83812000,
      "non_current_liabilities": 0,
      "non_operating_expenses": 0,
      "non_operating_income": 25134000,
      "operating_profit": -171842000,
      "revenue": 485923000,
      "sga_expenses": 270709000,
      "total_assets": 280957000,
      "total_equity": 247543000,
      "total_liabilities": 33414000
    },
    "2023": {
      "capital_stock": 222221000,
      "cost_of_sales": 228441000,
      "current_assets": 172781000,
      "current_liabilities": 39974000,
      "gross_profit": 184853000,
      "net_income": -46812000,
      "net_income_bs": -46812000,
      "non_current_assets": 67924000,
      "non_current_liabilities": 0,
      "non_operating_expenses": 0,
      "non_operating_income": 30761000,
      "operating_profit": -77573000,
      "revenue": 413294000,
      "sga_expenses": 262426000,
      "total_assets": 240705000,
      "total_equity": 200731000,
      "total_liabilities": 39974000
    },
    "2024": {
      "capital_stock": 257775000,
      "cost_of_sales": 109835000,
      "current_assets": 1582150000,
      "current_liabilities": 39907000,
      "gross_profit": 92061000,
      "net_income": -116520000,
      "net_income_bs": -116520000,
      "non_current_assets": 152672000,
      "non_current_liabilities": 59676000,
      "non_operating_expenses": 5454000,
      "non_operating_income": 30531000,
      "operating_profit": -141597000,
      "revenue": 201896000,
      "sga_expenses": 233658000,
      "total_assets": 1734822000,
      "total_equity": 1635239000,
      "total_liabilities": 99583000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [],
  "main_products": "압타머 발굴 원천기술/치료제",
  "phone": "042-936-****",
  "years": [
    2024,
    2023,
    2022
  ]
}